Do genetic factors reduce the effects of clopidogrel?

被引:0
|
作者
Scharf, Ruediger E. [1 ]
机构
[1] Univ Klinikum Dusseldorf, Inst Hamostaseol & Transfusionsmed, D-40225 Dusseldorf, Germany
关键词
TICAGRELOR; OUTCOMES; CYP2C19; ABCB1;
D O I
10.1055/s-0031-1275807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:786 / 786
页数:1
相关论文
共 50 条
  • [31] Factors associated with clopidogrel nonresponsiveness
    Momary, Kathryn M.
    Dorsch, Michael P.
    [J]. FUTURE CARDIOLOGY, 2010, 6 (02) : 195 - 210
  • [32] FACTORS THAT DECREASE THE EFFECTIVENESS OF CLOPIDOGREL
    Aschenbrenner, Diane S.
    [J]. AMERICAN JOURNAL OF NURSING, 2009, 109 (06) : 66 - 67
  • [33] Do laws restricting the use of genetic information reduce discrimination by health insurers?
    Hall, MA
    Rich, SS
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A3 - A3
  • [34] Do shrubs reduce the adverse effects of grazing on soil properties?
    Eldridge, David J.
    Beecham, Genevieve
    Grace, James B.
    [J]. ECOHYDROLOGY, 2015, 8 (08) : 1503 - 1513
  • [36] Calcium Channel Blockers Reduce the Antiplatelet Effect of Clopidogrel
    Siller-Matula, Jolanta
    Lang, Irene
    Christ, Guenter
    Jilma, Bernd
    [J]. CIRCULATION, 2008, 118 (18) : S375 - S375
  • [37] Clopidogrel and Genetic Testing: Is It Necessary for Everyone?
    Goswami, Sweta
    Cheng-Lai, Angela
    Nawarskas, James
    [J]. CARDIOLOGY IN REVIEW, 2012, 20 (02) : 96 - 100
  • [38] A genetic strategy to escalate clopidogrel dosing
    Marum, Lucy
    [J]. PHARMACOGENOMICS, 2012, 13 (02) : 134 - 134
  • [39] Resistance to clopidogrel: genetic and functional tests
    Hulotl, J. -S.
    Collet, J. -P.
    Montalescot, G.
    [J]. ARCHIVES OF CARDIOVASCULAR DISEASES SUPPLEMENTS, 2012, 4 (03) : 209 - 216
  • [40] Genetic determinants of platelet response to clopidogrel
    Kubica, Aldona
    Kozinski, Marek
    Grzesk, Grzegorz
    Fabiszak, Tomasz
    Navarese, Eliano Pio
    Goch, Aleksander
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (04) : 459 - 466